RT Journal Article
SR Electronic
T1 Evaluation of Xylem Discoloration in Ash Trees Associated with Macroinjections of a Systemic Insecticide
JF Arboriculture & Urban Forestry (AUF)
FD International Society of Arboriculture
SP 389
OP 399
DO 10.48044/jauf.2016.033
VO 42
IS 6
A1 Sara R. Tanis
A1 Deborah G. McCullough
YR 2016
UL http://auf.isa-arbor.com/content/42/6/389.abstract
AB Emerald ash borer (EAB) (Agrilus planipennis), first identified near Detroit, Michigan, U.S., in 2002, has killed millions of ash trees (Fraxinus spp.) in 28 states and two Canadian provinces to date. Trunk injections of insecticide products containing emamectin benzoate (EB) (e.g., TREE-äge®) are often used to protect ash trees in landscapes from EAB, but wounds and potential injury resulting from injections are a concern. Researchers examined 507 injection sites on 61 trees and recorded evidence of secondary wounding (e.g., external bark cracks, internal xylem necrosis and pathogen infection). Researchers assessed 233 injection sites on 22 green ash and 24 white ash trees macro-injected with a low or a medium-high rate of EB in 2008 only, or in both 2008 and 2009. Only 12 of 233 injection sites (5%) were associated with external bark cracks and there was no evidence of pathogen infection. On 39 of the 46 trees (85%), new xylem was growing over injection sites. Researchers assessed 274 injection sites on 15 green ash trees injected annually with EB from 2008 to 2013 or injected in 2008 and again in 2011. Bark cracks were associated with four injection sites on three trees, but no evidence of injury was found on the other 12 trees. All 15 trees had new xylem laid over injection sites. Confocal laser scanning and polarizing digital microscopy were used to assess the integrity of discolored xylem tissue removed from the immediate area surrounding 140 injection sites on 61 trees. Researchers found no evidence of decay associated with discoloration.